71288-165-54 : NDC 2026 Code

71288-165-54 : Nelarabine ( Nelarabine )

Additionally :

You can get information about “71288-165-54” NDC code in 71288-165-54 in HTML format

HTML | 71288-165-54 in TXT (Plain Text) format

TXT | 71288-165-54 in PDF (Portable Document Format)

PDF | 71288-165-54 in XML format

XML formats.

NDC Code : 71288-165-54 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "71288-165-54",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (71288-165-54)  / 50 mL in 1 VIAL, SINGLE-DOSE (71288-165-52) ",
    "NDC11Code": "71288-0165-54",
    "ProductNDC": "71288-165",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Nelarabine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Nelarabine",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20230110",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA216038",
    "LabelerName": "Meitheal Pharmaceuticals Inc",
    "SubstanceName": "NELARABINE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230110",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}